腹腔镜袖状胃切除术后远期效果分析

目的:评价腹腔镜袖状胃切除术治疗病态肥胖症的远期临床效果.方法:2005年9月至2009年9月为47例单纯性肥胖症患者施行腹腔镜袖状胃切除术,术后随访2年,观察体重指数变化和超重体重下降百分比.结果:术后患者均随访12个月以上,无严重并发症发生及营养不良,43例患者减重效果理想.结论:腹腔镜袖状胃切除术减重效果显著,远...     

不同体重指数单纯性肥胖患者腹腔镜胃袖状切除术后体重下降程度

目的 探讨不同体重指数(body mass index, BMI)的单纯性肥胖患者腹腔镜胃袖状切除术(laparoscopic sleeve gastrectomy, LSG)后体重下降程度。方法 回顾性分析2019年10月～2022年2月我科符合纳入标准的92例LSG资料，其中Ⅰ级肥胖(30≤BMI≤34.9)45例，Ⅱ级肥胖(35≤BMI≤39.9)30例，Ⅲ级肥胖(BMI≥40)17例。比较3组术后6个月多余体重减轻百分比(percentage of excess weight loss,%EWL)。采用Spearman相关分析计算术前BMI与术后1、3、6个月%EWL的相关性。结果 术后1、3、6个月Ⅰ级肥胖%EWL均明显高于Ⅱ级、Ⅲ级肥胖(P<0.05),Ⅱ级肥胖与Ⅲ级肥胖差异无统计学意义(P>0.05)。术前BMI与术后1、3、6个月%EWL存在负相关关系(r=-0.265,P=0.011;r=-0.347,P<0.001;r=-0.422,P<0.001)。结论 术前BMI越小，LSG术后体重下降程度越大。     

腹腔镜袖状胃切除术的疗效分析

目的:探讨腹腔镜袖状胃切除术治疗肥胖症的临床疗效及其相关并发症。方法:回顾分析2014年4月至2017年1月为28例肥胖症患者行腹腔镜袖状胃切除术的临床资料。术后随访患者体重、体重指数、血糖、糖化血红蛋白、血脂、血红蛋白、维生素B_(12)、叶酸等指标,计算多余体质量下降百分比。结果:28例患者均顺利完成手术,无中转开腹。随访3~36个月,术后患者体重、体重指数明显下降。2例患者减重效果欠佳,多余体质量下降百分比分别为47.2%与42.9%。10例患者合并2型糖尿病,其中8例仅靠生活及饮食可控制空腹血糖;术后血脂及其他相关肥胖并发症均得到明显缓解。2例合并胃食管反流病,术后未见缓解。无营养不良。结论:腹腔镜袖状胃切除术是高效、安全的减重手术,可明显缓解肥胖症患者的体重及相关肥胖并发症。     

腹腔镜袖状胃切除术治疗重度肥胖症的临床疗效

目的探讨腹腔镜下袖状胃切除术对重度肥胖症(体重指数BMI>35)的临床疗效。方法 2008年8月～2011年5月,对30例重度肥胖症患者实施腹腔镜袖状胃切除术,全身麻醉,腹腔镜下超声刀离断胃周韧带,术中电子胃镜指引下,使用Endo-GIA紧贴胃大弯侧行袖状胃切除。术后随访1年,观察BMI及超重体重下降百分比(excess weight loss,EWL%)的变化情况。结果 30例手术顺利,无术中并发症及中转开腹。术后1年体重指数(28.7±5.3)较术前(35.2±7.2)降低(t=3.98,P<0.001)。术后1年随访EWL%,根据Reinhold等制定的标准,效果极佳24例(80%)(EWL%76%～90%),良好6例(20%)(EWL%55%～73%)。结论腹腔镜袖状胃切除术治疗重度肥胖症近期疗效明显,长期疗效有待进一步观察。     

腹腔镜袖状胃切除术治疗非酒精性脂肪肝的临床研究

目的:探讨腹腔镜袖状胃切除术治疗肥胖症合并非酒精性脂肪肝的临床效果。方法:回顾分析2013年4月至2017年10月行腹腔镜袖状胃切除术并获完整随访24个月的26例肥胖症合并非酒精性脂肪肝患者的临床资料,分析患者手术前后体重、体重指数、血脂、脂肪肝的变化情况。结果:26例患者均顺利完成腹腔镜手术,术后无严重并发症发生。术后1、3、6、12、24个月随访,随访指标均低于术前,血脂恢复正常,非酒精性脂肪肝明显缓解。结论:腹腔镜袖状胃切除术是治疗肥胖症安全、有效的术式,减重效果确切,同时也是治疗脂肪肝的可靠方法,能显著降低体重与血脂,逆转脂肪肝。     

腹腔镜胃袖状切除术的技术细节

<正>腹腔镜胃袖状切除(laparoscopic sleeve gastrectomy,LSG)是目前常用减重手术技术。由于其相对胃旁路术简单、安全,术后营养问题较少,且其减重与代谢改善效果不亚于胃旁路术,近年得以广泛应用,在世界范围内约50%减重手术方式为腹腔镜胃袖状切除术[1-2]。为了规范的开展此种手术,获得理想减重效果,减少并发症发生机会,本文结合     

术前饮食行为对减重手术效果的影响

目的: 探讨术前饮食行为对减重手术效果的影响,为预测减重手术效果提供参考。方法: 采用荷兰饮食行为问卷（Dutch Eating Behavior Questionnaire, DEBQ）及相关评分标准,对85例肥胖症行腹腔镜胃袖状切除的减重手术病人进行分组,分为限制性饮食组44例和非限制性饮食组41例,其中限制性饮食组再分为成功限制亚组27例与失败限制亚组17例。分别比较术前不同饮食行为组及亚组之间术后6、12个月的体重、体质量指数（body mass index, BMI）及多余体重减少率（excess weight loss, %EWL）改变。结果: 85例病人均成功接受减重手术。限制饮食组术后6、12个月体重和BMI显著高于非限制组,%EWL显著低于非限制组。限制饮食组中,成功限制亚组术后6、12个月体重和BMI显著高于失败限制亚组,%EWL显著低于失败限制亚组。结论: 术前饮食行为显著影响减重手术结果,可作为预测减重手术效果的参考。     

腹腔镜袖状胃切除术的临床效果与并发症

腹腔镜袖状胃切除术作为一种相对新型的胃肠道代谢-减重手术近年得到迅速开展。大量研究表明,腹腔镜袖状胃切除术具有减重及显著缓解2型糖尿病等肥胖并存症的效果,但同时也有某些潜在性并发症。本文现就腹腔镜袖状胃切除术的手术效果及并发症作一文献综述。     

腹腔镜可调节捆扎带胃减容与袖状胃切除术治疗病态肥胖症对比分析

【摘要】目的 评价腹腔镜可调节捆扎带胃减容术及袖状胃切除术治疗病态肥胖症的效果。方法 2006年3月至2007年7月中国医科大学附属盛京医院对23例肥胖病人施行腹腔镜减肥手术,其中17例施行腹腔镜可调节捆扎带胃减容术（LAGB）,6例施行腹腔镜袖状胃切除术（LSG）,对其疗效进行随访观察。 结果 施行腹腔镜可调节捆扎带胃减容术或袖状胃切除术者均获得12个月以上的随访,术后减重效果理想,无营养不良症状。 结论 袖状胃切除术操作简单、无异物植入体内、并发症少,利于开展此项手术。但两种术式远期疗效仍需深入研究、对比观察。     

腹腔镜袖状胃切除术36例近期疗效分析

目的探讨行腹腔镜袖状胃切除术治疗肥胖症的临床疗效和可行性。方法回顾性分析2010年4月至2013年12月行腹腔镜袖状胃切除术治疗肥胖症36例患者的资料和术后12个月随访资料。应用SPSS 17.0统计软件进行分析,患者术后1、3、6、12个月体重、BMI(术后各时间点与术前)比较采用配对t检验,以P<0.05为差异有统计学意义。结果所有患者均在腹腔镜下完成手术,无中转开腹。术中术后均无严重并发症发生。在术后12个月的随访过程中,患者体重、体质指数均呈下降趋势,与术前(104.3±22.4)kg、(37.4±5.8)kg/m2相比,术后1个月、3个月、6个月、12个月体重及体质指数分别为(95.1±16.1)kg、(34.6±5.2)kg/m2;(89.3±15.2)kg、(32.1±4.6)kg/m2;(82.1±12.3)kg、(30.3±4.2)kg/m2;(78.3±10.1)kg、(28.5±3.8)kg/m2,差异均有统计学意义(P<0.05或P<0.01)。结论腹腔镜袖状胃切除术是一种安全、有效的治疗肥胖症的手术方式。     

机器人辅助袖状胃切除联合胃底折叠治疗肥胖症合并食管裂孔疝的单中心回顾性分析

背景与目的 肥胖症患者常常合并食管裂孔疝并伴有胃食管反流症状，袖状胃切除术后可能造成严重的并发症。机器人辅助系统具有学习曲线短且平缓、手术视野清晰立体以及手术操作精确且稳定等优势，在外科领域得以广泛推广。本研究探究机器人辅助袖状胃切除联合胃底折叠手术的可行性，从而为肥胖症合并食管裂孔疝患者提供更佳的治疗方案。方法 回顾性分析2019年3月—2021年12月期间49例肥胖症合并食管裂孔疝行袖状胃切除及胃底折叠手术治疗患者的临床资料。其中22例行机器人辅助袖状胃切除联合胃底折叠术（机器人组），27例行腹腔镜辅助袖状胃切除联合胃底折叠术（腹腔镜组）。比较两组患者围手术期相关临床指标的差异，并分析机器人组的治疗效果。结果 两组患者术前甘油三酯、术前空腹血糖、术后住院时间、并发症发生率差异无统计学意义（均P>0.05）。与腹腔镜组比较，机器人组平均手术时间延长（169.09 min vs. 143.33 min，P=0.023）、平均手术费增加（6.36万元vs. 5.40万元，P<0.001），但手术操作时间缩短（115.09 min vs. 134.19 min，P=0.047），出血量减少（25.45 mL vs. 40.00 mL，P=0.023）。两组患者术后1个月的BMI、多余体质量减少百分比（%EWL）、甘油三酯、空腹血糖以及GERD评分差异均无统计学意义（均P>0.05）。机器人组术后1个月的%EWL值（26.26%）达到了减重有效的水平，术后1个月的体质量、BMI、甘油三酯、空腹血糖以及GERD评分均较术前明显降低（均P<0.05）。结论 机器人辅助袖状胃切除联合胃底折叠手术能够使肥胖合并食管裂孔疝患者获得良好的减重效果，明显改善患者的代谢和胃食管反流症状，并且安全可靠，具有一定的可行性。但手术费用较高的问题亟待解决，在选择手术方式时应充分考虑患者家庭经济情况。     

两种代谢手术治疗肥胖型2型糖尿病的对比分析

目的评价两种手术方式对治疗肥胖伴有2型糖尿病(T2DM)的优势。 方法回顾分析2012年1月至2019年2月两家医院收治的64例肥胖伴有T2DM的临床资料,根据手术干预情况分为两组,腹腔镜下SG(LSG组) 30例和腹腔镜下胃旁路手术(L-RYGB组) 34例,采用SPSS 17软件进行统计分析。生化指标等计量资料以( ±s)表示,采用独立t检验。术后并发症等计数资料采用χ²检验,采用logistic回归(逐步)模型,分析T2DM缓解与否的危险因素,P<0.05为差异有统计学意义。 结果两组患者术后1年血脂相关指标除甘油三酯外,两种手术方法均未获得明显改善。两组间BMI和血糖比较差异无统计学意义(P>0.05);L-RYGB对血糖的缓解率(88.2%)优于LSG(76.7%)P<0.05。而术后1年,两组接受治疗的患者的HbA1c、收缩压和舒张压减少值均明显降低(P＝0.016; P＝0.029和P＝0.017),多因素logistic回归分析,BMI、空腹血糖、HbA1c可作为1年时T2DM缓解的独立危险因素(P＝0.001; P＝0.001; P＝0.008)。L-RYGB显示出T2DM缓解率明显高于LSG (OR＝1.79, 95%CI: 1.133～2.829, P＝0.013)。两组患者均未发生30d内死亡和胃肠瘘。在深静脉血栓形成的并发症中,L-RYGB的发生率较高(11.8% vs.3.3%, P＝0.022)。 结论在T2DM缓解方面,术后1年的结论,L-RYGB优于LSG。远期持久缓解的结果,仍需更长时间的随访研究。     

Heterogeneity of weight loss after gastric bypass,sleeve gastrectomy,and adjustable gastric banding

Background

Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.

Laparoscopic Sleeve Gastrectomy as an Alternative to Gastric Bypass in Patients with Multiple Intraabdominal Adhesions

Background Laparoscopic sleeve gastrectomy and its indications are currently being evaluated. The objective of this study was to show the preliminary results obtained with this technique indicated as an alternative to gastric bypass in patients with multiple intraabdominal adhesions, therefore preserving the benefits of the laparoscopic approach. Methods An analysis of all patients who underwent a laparoscopic sleeve gastrectomy for the above indication was done. Data included demographics, number of previous surgeries, operative time, morbidity, mortality, and %EWL at 3 and 6 months. Results Fifteen patients underwent laparoscopic sleeve gastrectomy as an alternative to gastric bypass because of multiple intraabdominal adhesions. No patient required conversion to an open procedure; morbidity was 6% with no mortality. %EWL at 3 months was 41% and at 6 months was 44%. Mean follow-up was 6 months. Conclusion In our initial experience, laparoscopic sleeve gastrectomy proved to be a safe and effective alternative to gastric bypass for patients with multiple intraabdominal adhesions.     

腹腔镜袖状胃切除术治疗病态性肥胖症合并2型糖尿病的疗效及相关因素分析

目的:探讨腹腔镜袖状胃切除术(LSG)治疗病态性肥胖症合并2型糖尿病的临床疗效,并分析影响疗效的相关因素.方法:回顾分析2013年7月至2018年7月为45例病态性肥胖症合并2型糖尿病患者行LSG的临床资料及随访情况,分析手术对患者体重及血糖的控制情况,并应用单因素与多因素Logistic回归分析影响体重及血糖控制效果...     

Patient Characteristics Impacting Excess Weight Loss following Laparoscopic Adjustable Gastric Banding

Background: Weight loss is more variable after laparoscopic adjustable gastric banding (LAGB) than after gastric bypass. Subgroup analysis of patients may offer insight into this variability. The aim of our study was to identify preoperative factors that predict outcome. Methods: Demographics, co-morbid conditions and follow-up weight were collected for our 1st 200 LapBand ? patients. Linear regression determined average %EWL. Logistic regression analysis identified factors that impacted %EWL. Result: 200 patients returned for 778 follow-up visits. Median age was 44 years (21-72) and median BMI 45 kg/m² (31-76). 140 (80%) were women. Average %EWL was y % = 0.007 %/day (days since surgery) + 0.12% (correlation coef. 0.4823; P<0.001). %EWL at 1 year was 37%. The best-fit logistic regression model found 7 factors that significantly changed the odds of achieving average %EWL. Older patients, diabetic patients and patients with COPD had greater odds of above average %EWL. Female patients, patients with larger BMIs, asthmatic patients and patients with hypertension had increased odds of below average %EWL. Conclusion: Specific patient characteristics and comorbid conditions significantly altered the odds of achieving satisfactory %EWL following gastric banding.     

Does Gastric Dilatation Limit the Success of Sleeve Gastrectomy as a Sole Operation for Morbid Obesity?

Background: Sleeve gastrectomy as the sole bariatric operation has been reported for high-risk super-obese patients or as first-step followed by Roux-en-Y gastric bypass (RYGBP) or duodenal switch (DS) in super-super obese patients. The efficacy of laparoscopic sleeve gastrectomy (LSG) for morbidly obese patients with a BMI of <50 kg/m² and the incidence of gastric dilatation following LSG have not yet been investigated. Methods: 23 patients (15 morbidly obese, 8 super-obese) were studied prospectively for weight loss following LSG. The incidence of sleeve dilatation was assessed by upper GI contrast studies in patients with a follow-up of >12 months. Results: Patients who underwent LSG achieved a mean excess weight loss (EWL) at 6 and 12 months postoperatively of 46% and 56%, respectively. No significant differences were observed in %EWL comparing obese and super-obese patients. At a mean follow-up of 20 months, dilatation of the gastric sleeve was found in 1 patient and weight regain after initial successful weight loss in 3 of the 23 patients. Conclusion: LSG has been highly effective for weight reduction for morbid obesity even as the sole bariatric operation. Gastric dilatation was found in only 1 patient in this short-term follow-up. Weight regain following LSG may require conversion to RYGBP or DS. Follow-up will be necessary to evaluate long-term results.     

Laparoscopic re-sleeve gastrectomy as a treatment of weight regain after sleeve gastrectomy

AIM: To evaluate laparoscopic re-sleeve gastrectomy as a treatment of weight regain after Sleeve.METHODS: Laparoscopic sleeve gastrectomy is a com-mon bariatric procedure. Weight regain after long-term follow-up is reported. Patients were considered for laparoscopic re-sleeve gastrectomy when we observed progressive weight regain and persistence of comorbid-ities associated with evidence of dilated gastric fundus and/or antrum on upper gastro-intestinal series. Follow-up visits were scheduled at 1, 3, 6 and 12 mo after surgery and every 6 mo thereafter. Measures of change from baseline at different times were analyzed with the paired samples t test. RESULTS: We observed progressive weight regain after sleeve in 11 of the 201 patients(5.4%) who had a mean follow-up of 21.1 ± 9.7 mo(range 6-57 mo). Three patients started to regain weight after 6 mo fol-lowing Sleeve, 5 patients after 12 mo, 3 patients after 18 m. Re-sleeve gastrectomy was always performed by laparoscopy. The mean time of intervention was 55.8 ± 29.1 min. In all cases, neither intra-operative nor post-operative complications occurred. After 1 year follow-up we observed a significant(P 0.05) mean body mass index reduction(-6.6 ± 2.7 kg/m2) and mean % ex-cess weight loss(%EWL) increase(+31.0% ± 15.8%). An important reduction of antihypertensive drugs and hypoglycemic agents was observed after re-sleeve in those patients affected by hypertension and diabetes. Joint problems and sleep apnea syndrome improved in all 11 patients.CONCLUSION: Laparoscopic re-sleeve gastrectomy is a feasible and effective intervention to correct weight regain after sleeve.     

Sleeve gastrectomy with wrapping using polytetrafluoroethylene to prevent gastric enlargement in a porcine model

BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy followed by biliopancreatic diversion with duodenal switch for morbid obesity has been well established. We previously recommended 2-stage laparoscopic biliopancreatic diversion with duodenal switch for super-super obese patients. In the 2-stage version, these patients undergo laparoscopic sleeve gastrectomy as a first-stage procedure, followed by laparoscopic biliopancreatic diversion with duodenal switch as the second stage for more definitive treatment of their obesity. However, short-term weight regain may occur owing to gastric dilation after initial laparoscopic sleeve gastrectomy. The aim of this study was to prevent gastric dilation after sleeve gastrectomy. We designed a sleeve gastrectomy with wrapping using polytetrafluoroethylene dual mesh. METHODS: Eleven Yorkshire pigs weighing 20-25 kg underwent sleeve gastrectomy with wrapping using polytetrafluoroethylene dual mesh (wrapping group) or sleeve gastrectomy only (control group) to compare the weight loss. The animals were weighed weekly postoperatively. Necropsy was performed 8 weeks postoperatively to confirm the wrapping by pathologic report. RESULTS: Four pigs died because of staple line failure or strangulation; no perioperative complications occurred in the other pigs. The operative time for the control group was 198 +/- 60 minutes and for the wrapping group was 181 +/- 86 minutes (P = NS). The average weight of the removed stomach was 123.3 +/- 5.8 g in the control group and 140.3 +/- 69.9 g in the wrapping group (P = NS). The postoperative weight gain at 8 weeks was significantly slower in the wrapping group than in the control group (P <.0001). The pathologic necropsy report noted that the mesh was well attached to the stomach wall at 9 days postoperatively, with no unexpected deaths. CONCLUSION: Sleeve gastrectomy with wrapping using polytetrafluoroethylene dual mesh is feasible, and weight gain was reduced in the porcine model.